Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should hyperthermia be included in the benefit catalogue for oncologic indications? Commercial interests are presumed behind the editorial of R. Sauer et al.

Literature DB >> 23203532

Should hyperthermia be included in the benefit catalogue for oncologic indications? Commercial interests are presumed behind the editorial of R. Sauer et al.

C Wild.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 23203532 DOI： 10.1007/s00066-012-0265-2

Source DB: PubMed Journal: Strahlenther Onkol ISSN： 0179-7158 Impact factor: 3.621

× No keyword cloud information.

13 in total

1. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Authors: Rolf D Issels; Lars H Lindner; Jaap Verweij; Peter Wust; Peter Reichardt; Baard-Christian Schem; Sultan Abdel-Rahman; Soeren Daugaard; Christoph Salat; Clemens-Martin Wendtner; Zeljko Vujaskovic; Rüdiger Wessalowski; Karl-Walter Jauch; Hans Roland Dürr; Ferdinand Ploner; Andrea Baur-Melnyk; Ulrich Mansmann; Wolfgang Hiddemann; Jean-Yves Blay; Peter Hohenberger
Journal: Lancet Oncol Date: 2010-04-29 Impact factor: 41.316

2. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.

Authors: C C Vernon; J W Hand; S B Field; D Machin; J B Whaley; J van der Zee; W L van Putten; G C van Rhoon; J D van Dijk; D González González; F F Liu; P Goodman; M Sherar
Journal: Int J Radiat Oncol Biol Phys Date: 1996-07-01 Impact factor: 7.038

3. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

Authors: Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud
Journal: Ann Intern Med Date: 2008-02-19 Impact factor: 25.391

4. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma.

Authors: Y Harima; K Nagata; K Harima; V V Ostapenko; Y Tanaka; S Sawada
Journal: Int J Hyperthermia Date: 2001 Mar-Apr Impact factor: 3.914

5. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors: J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal: Lancet Date: 2000-04-01 Impact factor: 79.321

6. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.

Authors: Arumugam Vasanthan; Michihide Mitsumori; Jeong Ho Park; Zeng Zhi-Fan; Zhong Yu-Bin; Praskovya Oliynychenko; Hideo Tatsuzaki; Yoshiaki Tanaka; Masahiro Hiraoka
Journal: Int J Radiat Oncol Biol Phys Date: 2005-01-01 Impact factor: 7.038

7. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal: PLoS Med Date: 2009-07-21 Impact factor: 11.069

8. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.

Authors: Martine Franckena; Lukas J A Stalpers; Peter C M Koper; Ruud G J Wiggenraad; Wim J Hoogenraad; Jan D P van Dijk; Carla C Wárlám-Rodenhuis; Jan J Jobsen; Gerard C van Rhoon; Jacoba van der Zee
Journal: Int J Radiat Oncol Biol Phys Date: 2007-09-19 Impact factor: 7.038

9. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).

Authors: Renzo Colombo; Andrea Salonia; Zvi Leib; Michele Pavone-Macaluso; Dov Engelstein
Journal: BJU Int Date: 2010-10-04 Impact factor: 5.588